OMB
.report
Search
Main Study Screener
Risk and Benefit Perception Scale Development
OMB: 0910-0784
IC ID: 214031
OMB.report
HHS/FDA
OMB 0910-0784
ICR 201411-0910-015
IC 214031
( )
⚠️ Notice: This information collection may be referencing outdated material. More recent filings for OMB 0910-0784 can be found here:
2015-10-19 - No material or nonsubstantive change to a currently approved collection
2015-06-10 - No material or nonsubstantive change to a currently approved collection
Documents and Forms
Document Name
Document Type
SURVEY QUESTIONNAIRE 10-28-14.docx
Other-Questionnaire
SCALE DEVELOPMENT 30 DAY FRN 10-28-14.doc
Scale Development
IC Document
Information Collection (IC) Details
View Information Collection (IC)
IC Title:
Main Study Screener
Agency IC Tracking Number:
Is this a Common Form?
No
IC Status:
New
Obligation to Respond:
Voluntary
CFR Citation:
Information Collection Instruments:
Document Type
Form No.
Form Name
Instrument File
URL
Available Electronically?
Can Be Submitted Electronically?
Electronic Capability
Other-Questionnaire
SURVEY QUESTIONNAIRE 10-28-14.docx
Yes
Yes
Fillable Fileable
Federal Enterprise Architecture Business Reference Module
Line of Business:
Health
Subfunction:
Consumer Health and Safety
Privacy Act System of Records
Title:
FR Citation:
Number of Respondents:
20,000
Number of Respondents for Small Entity:
0
Affected Public:
Individuals or Households
Percentage of Respondents Reporting Electronically:
100 %
Approved
Program Change Due to New Statute
Program Change Due to Agency Discretion
Change Due to Adjustment in Agency Estimate
Change Due to Potential Violation of the PRA
Previously Approved
Annual Number of Responses for this IC
20,000
0
20,000
0
0
0
Annual IC Time Burden (Hours)
600
0
600
0
0
0
Annual IC Cost Burden (Dollars)
0
0
0
0
0
0
Documents for IC
Title
Document
Date Uploaded
Scale Development
SCALE DEVELOPMENT 30 DAY FRN 10-28-14.doc
11/25/2014
Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.